University of Florida - Gainesville - 1600 SW Archer Rd — Gainesville, Florida

University of Florida - Gainesville - 1600 SW Archer Rd is a clinical research site located in Gainesville, Florida, United States 32610-3003.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Florida - Gainesville - 1600 SW Archer Rd has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Alpha 1-Antitrypsin Deficiency, Emphysema, Immunoglobulin A Nephropathy (IgAN).

Sponsors: Sanofi, Biogen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Gainesville

Browse all research sites in Florida · View every site in Gainesville

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Florida - Gainesville - 1600 SW Archer Rd?

University of Florida - Gainesville - 1600 SW Archer Rd has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Florida - Gainesville - 1600 SW Archer Rd conducted?

University of Florida - Gainesville - 1600 SW Archer Rd has 2 clinical trials on record, with 2 currently active. Their work covers Alpha 1-Antitrypsin Deficiency, Emphysema, Immunoglobulin A Nephropathy (IgAN).

Is University of Florida - Gainesville - 1600 SW Archer Rd accredited by Crixeo Clinical Trials?

University of Florida - Gainesville - 1600 SW Archer Rd has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Florida - Gainesville - 1600 SW Archer Rd?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.